Impact of Lipid-Lowering Therapy on Mortality According to the Baseline Non-HDL Cholesterol Level: A Meta-Analysis

ConclusionsIn these meta-analyses, lipid-lowering therapy was associated with reduction in the risk of all-cause and cardiovascular mortality when baseline non-HDL-C levels were above than 130  mg/dL.

Source: High Blood Pressure and Cardiovascular Prevention - July 15, 2019 Category: Cardiology Source Type: research